Cytoplasmic Targeting Motifs Control Localization of Toll-like Receptor 9

Overview

Journal J Biol Chem

Specialty Biochemistry

Date 2006 Sep 23

PMID 16990271

Citations 38

Authors

Cynthia A Leifer

James C Brooks

Karin Hoelzer

Jody Lopez

Margaret N Kennedy

Alessandra Mazzoni

David M Segal

Affiliations

Soon will be listed here.

Abstract

Toll-like receptors (TLRs) are essential for host defense. Although several TLRs reside on the cell surface, nucleic acid recognition of TLRs occurs intracellularly. For example, the receptor for CpG containing bacterial and viral DNA, TLR9, is retained in the endoplasmic reticulum. Recent evidence suggests that the localization of TLR9 is critical for appropriate ligand recognition. Here we have defined which structural features of the TLR9 molecule control its intracellular localization. Both the cytoplasmic and ectodomains of TLR9 contain sufficient information, whereas the transmembrane domain plays no role in intracellular localization. We identify a 14-amino acid stretch that directs TLR9 intracellularly and confers intracellular localization to the normally cell surface-expressed TLR4. Truncation or mutation of the cytoplasmic tail of TLR9 reveals a vesicle localization motif that targets early endosomes. We propose a model whereby modification of the cytoplasmic tail of TLR9 results in trafficking to early endosomes where it encounters CpG DNA.

Citing Articles

Surface toll-like receptor 9 on immune cells and its immunomodulatory effect.

Kou M, Wang L Front Immunol. 2023; 14:1259989.

PMID: 37724102 PMC: 10505433. DOI: 10.3389/fimmu.2023.1259989.

The Signal Peptide and Chaperone UNC93B1 Both Influence TLR8 Ectodomain Intracellular Endosomal Localization.

Ao D, Liu X, Jiang S, Xu Y, Zheng W, Chen N Vaccines (Basel). 2022; 10(1).

PMID: 35062674 PMC: 8778924. DOI: 10.3390/vaccines10010014.

Immunomodulatory Nanoparticles Mitigate Macrophage Inflammation via Inhibition of PAMP Interactions and Lactate-Mediated Functional Reprogramming of NF-κB and p38 MAPK.

Lasola J, Cottingham A, Scotland B, Truong N, Hong C, Shapiro P Pharmaceutics. 2021; 13(11).

PMID: 34834256 PMC: 8618039. DOI: 10.3390/pharmaceutics13111841.

Cell Surface Expression of Endosomal Toll-Like Receptors-A Necessity or a Superfluous Duplication?.

Mielcarska M, Bossowska-Nowicka M, Toka F Front Immunol. 2021; 11:620972.

PMID: 33597952 PMC: 7882679. DOI: 10.3389/fimmu.2020.620972.

Toll-Like Receptor 9 Agonists in Cancer.

Karapetyan L, Luke J, Davar D Onco Targets Ther. 2020; 13:10039-10060.

PMID: 33116588 PMC: 7553670. DOI: 10.2147/OTT.S247050.

References

Takeda K, Kaisho T, Akira S . Toll-like receptors. Annu Rev Immunol. 2003; 21:335-76. DOI: 10.1146/annurev.immunol.21.120601.141126. View

Lund J, Sato A, Akira S, Medzhitov R, Iwasaki A . Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells. J Exp Med. 2003; 198(3):513-20. PMC: 2194085. DOI: 10.1084/jem.20030162. View

Matsumoto M, Funami K, Tanabe M, Oshiumi H, Shingai M, Seto Y . Subcellular localization of Toll-like receptor 3 in human dendritic cells. J Immunol. 2003; 171(6):3154-62. DOI: 10.4049/jimmunol.171.6.3154. View

Bonifacino J, Traub L . Signals for sorting of transmembrane proteins to endosomes and lysosomes. Annu Rev Biochem. 2003; 72:395-447. DOI: 10.1146/annurev.biochem.72.121801.161800. View

Dunne A, Ejdeback M, Ludidi P, ONeill L, Gay N . Structural complementarity of Toll/interleukin-1 receptor domains in Toll-like receptors and the adaptors Mal and MyD88. J Biol Chem. 2003; 278(42):41443-51. DOI: 10.1074/jbc.M301742200. View

Heil F, Ahmad-Nejad P, Hemmi H, Hochrein H, Ampenberger F, Gellert T . The Toll-like receptor 7 (TLR7)-specific stimulus loxoribine uncovers a strong relationship within the TLR7, 8 and 9 subfamily. Eur J Immunol. 2003; 33(11):2987-97. DOI: 10.1002/eji.200324238. View

Yamamoto M, Takeda K, Akira S . TIR domain-containing adaptors define the specificity of TLR signaling. Mol Immunol. 2003; 40(12):861-8. DOI: 10.1016/j.molimm.2003.10.006. View

Latz E, Schoenemeyer A, Visintin A, Fitzgerald K, Monks B, Knetter C . TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat Immunol. 2004; 5(2):190-8. DOI: 10.1038/ni1028. View

Diebold S, Kaisho T, Hemmi H, Akira S, Reis e Sousa C . Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science. 2004; 303(5663):1529-31. DOI: 10.1126/science.1093616. View

10.

Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, Akira S . Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science. 2004; 303(5663):1526-9. DOI: 10.1126/science.1093620. View

11.

Zhang D, Zhang G, Hayden M, Greenblatt M, Bussey C, Flavell R . A toll-like receptor that prevents infection by uropathogenic bacteria. Science. 2004; 303(5663):1522-6. DOI: 10.1126/science.1094351. View

12.

Subramaniam S, Stansberg C, Cunningham C . The interleukin 1 receptor family. Dev Comp Immunol. 2004; 28(5):415-28. DOI: 10.1016/j.dci.2003.09.016. View

13.

Nishiya T, DeFranco A . Ligand-regulated chimeric receptor approach reveals distinctive subcellular localization and signaling properties of the Toll-like receptors. J Biol Chem. 2004; 279(18):19008-17. DOI: 10.1074/jbc.M311618200. View

14.

Leifer C, Kennedy M, Mazzoni A, Lee C, Kruhlak M, Segal D . TLR9 is localized in the endoplasmic reticulum prior to stimulation. J Immunol. 2004; 173(2):1179-83. PMC: 2757936. DOI: 10.4049/jimmunol.173.2.1179. View

15.

Khan J, Brint E, ONeill L, Tong L . Crystal structure of the Toll/interleukin-1 receptor domain of human IL-1RAPL. J Biol Chem. 2004; 279(30):31664-70. DOI: 10.1074/jbc.M403434200. View

16.

Uchiyama T, Nelson D, Fleisher T, Waldmann T . A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. II. Expression of Tac antigen on activated cytotoxic killer T cells, suppressor cells, and on one of two types of helper T cells. J Immunol. 1981; 126(4):1398-403. View

17.

Bonifacino J, DellAngelica E . Molecular bases for the recognition of tyrosine-based sorting signals. J Cell Biol. 1999; 145(5):923-6. PMC: 2133128. DOI: 10.1083/jcb.145.5.923. View

18.

Nishiya T, Kajita E, Miwa S, DeFranco A . TLR3 and TLR7 are targeted to the same intracellular compartments by distinct regulatory elements. J Biol Chem. 2005; 280(44):37107-17. DOI: 10.1074/jbc.M504951200. View

19.

Barton G, Kagan J, Medzhitov R . Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA. Nat Immunol. 2005; 7(1):49-56. DOI: 10.1038/ni1280. View

20.

Kajita E, Nishiya T, Miwa S . The transmembrane domain directs TLR9 to intracellular compartments that contain TLR3. Biochem Biophys Res Commun. 2006; 343(2):578-84. DOI: 10.1016/j.bbrc.2006.03.014. View